Replies to post #84891 on Biotech Values

[DewDiligence]

From page 3 of Lev’s 2007 10K report:

We intend to initiate a research program in 2007 for the development of a genetically engineered or recombinant version of C1-INH to be used in the treatment of AMI.

http://sec.gov/Archives/edgar/data/1144062/000114420407015593/v069942_10ksb.htm